Market Cap

Editas Medicine, Inc. Market Capitalization:

$200.1 Million

USD as of Jan. 1, 2026

business Editas Medicine, Inc. Company Profile

Editas Medicine, Inc. Main Stock Listing

NASDAQ: EDIT

Market Capitalization History of Editas Medicine, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Editas Medicine, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $200.1 M 71.93%
Jan. 1, 2025 $116.4 M -84.32%
Jan. 1, 2024 $742.4 M 28.07%
Jan. 1, 2023 $579.7 M -55.72%
Jan. 1, 2022 $1.31 B -68.96%
Jan. 1, 2021 $4.22 B 132.12%
Jan. 1, 2020 $1.82 B 21.63%
Jan. 1, 2019 $1.49 B -40.48%
Jan. 1, 2018 $2.51 B 109.59%
Jan. 1, 2017 $1.20 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Editas Medicine, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Editas Medicine, Inc. has the following listings and related stock indices.


Stock: NASDAQ: EDIT

Stock: FSX: 8EM

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.